Cutaquig 165 mg/ml otopina za injekciju
| Name | Cutaquig 165 mg/ml otopina za injekciju |
|---|---|
| Marketing Authorisation Number | HR-H-514594759 |
| Active Substance | imunoglobulin normalni, ljudski |
| Composition | jedan ml otopine sadrži: imunoglobulin normalni ljudski 165 mg (čistoće od najmanje 95% IgG) |
| Pharmaceutical Form | otopina za injekciju |
| Manufacturer | Octapharma Pharmazeutika Produktionsges.m.b.H., Beč, Austrija Octapharma AB, Stockholm, Švedska |
| Marketing Authorisation Holder | Octapharma (IP) SPRL, Route de Lennik 451, Anderlecht, Belgija |
| Marketing Authorisation Date | 07.12.2023 |
| MA Period of Validity | unlimited |
| Classification Number | UP/I-530-09/23-02/74 |
| Registration Number | 381-12-01/70-23-06 |
| Prescription | Medicinal product subject to medical prescription |
| Type of prescription | Medicinal product subject to restricted medical prescription |
| Distribution | Supply through pharmacies (community) |
| Advertising to general public | not allowed |
| ATC Code | J06BA01 |
| Marketing status | Marketed |
| Shortage status | No shortage |
| SmPC | download |
| PL | download |
| Public Assessment Report | download |
